Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan W Said

Showing results (31-40 of 126) with videos related to

Pageof 13
Sort By:
Cancer Research|May 3, 2008
Targeted deletion of hepatic Igf1 in TRAMP mice leads to dramatic alterations in the circulating insulin-like growth factor axis but does not reduce tumor progressionMakoto Anzo, Laura J Cobb, David L Hwang, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|November 24, 2006
An inverse relation between COX-2 and E-cadherin expression correlates with aggressive histologic features in prostate cancerDinesh S Rao, Dorina Gui, Michelle E Koski, et al.
Human Immunology|May 4, 2004
Anti-HLA class I antibody-mediated activation of the PI3K/Akt signaling pathway and induction of Bcl-2 and Bcl-xL expression in endothelial cellsYi-Ping Jin, Michael C Fishbein, Jonathan W Said, et al.
The Journal of Biological Chemistry|October 9, 2004
Cyr61 suppresses growth of human endometrial cancer cellsWenwen Chien, Takashi Kumagai, Carl W Miller, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2004
RWJ-241947 (MCC-555), a unique peroxisome proliferator-activated receptor-gamma ligand with antitumor activity against human prostate cancer in vitro and in beige/nude/ X-linked immunodeficient mice and enhancement of apoptosis in myeloma cells induced by arsenic trioxideTakashi Kumagai, Takayuki Ikezoe, Dorina Gui, et al.
Leukemia Research|April 18, 2008
Megakaryocytic blast crisis as a presenting manifestation of chronic myeloid leukemiaSheeja T Pullarkat, James W Vardiman, Marilyn L Slovak, et al.
Urology|May 30, 2017
Prostate Cancer Antigen 3 Score Does Not Predict for Adverse Pathologic Features at Radical Prostatectomy or for Progression-free Survival in Clinically Localized, Intermediate- and High-risk Prostate CancerJohn V Hegde, Darlene Veruttipong, Jonathan W Said, et al.
International Journal of Cancer|October 14, 2014
Synergistic effect of JQ1 and rapamycin for treatment of human osteosarcomaDhong Hyun Lee, Jun Qi, James E Bradner, et al.
Leukemia Research|May 4, 2004
Allelic loss during progression of follicular lymphomaSeisho Takeuchi, Sven de Vos, Naoko Takeuchi, et al.
The Journal of Urology|November 17, 2007
In vivo efficacy of laparoscopic assisted percutaneous renal cryotherapy: evidence based guidelines for the practicing urologistAlberto Breda, John S Lam, Stephen Riggs, et al.
Pageof 13

Showing results (31-40 of 126) with videos related to

Sort By:
Pageof 13
Cancer Research|May 3, 2008
Targeted deletion of hepatic Igf1 in TRAMP mice leads to dramatic alterations in the circulating insulin-like growth factor axis but does not reduce tumor progressionMakoto Anzo, Laura J Cobb, David L Hwang, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|November 24, 2006
An inverse relation between COX-2 and E-cadherin expression correlates with aggressive histologic features in prostate cancerDinesh S Rao, Dorina Gui, Michelle E Koski, et al.
Human Immunology|May 4, 2004
Anti-HLA class I antibody-mediated activation of the PI3K/Akt signaling pathway and induction of Bcl-2 and Bcl-xL expression in endothelial cellsYi-Ping Jin, Michael C Fishbein, Jonathan W Said, et al.
The Journal of Biological Chemistry|October 9, 2004
Cyr61 suppresses growth of human endometrial cancer cellsWenwen Chien, Takashi Kumagai, Carl W Miller, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2004
RWJ-241947 (MCC-555), a unique peroxisome proliferator-activated receptor-gamma ligand with antitumor activity against human prostate cancer in vitro and in beige/nude/ X-linked immunodeficient mice and enhancement of apoptosis in myeloma cells induced by arsenic trioxideTakashi Kumagai, Takayuki Ikezoe, Dorina Gui, et al.
Leukemia Research|April 18, 2008
Megakaryocytic blast crisis as a presenting manifestation of chronic myeloid leukemiaSheeja T Pullarkat, James W Vardiman, Marilyn L Slovak, et al.
Urology|May 30, 2017
Prostate Cancer Antigen 3 Score Does Not Predict for Adverse Pathologic Features at Radical Prostatectomy or for Progression-free Survival in Clinically Localized, Intermediate- and High-risk Prostate CancerJohn V Hegde, Darlene Veruttipong, Jonathan W Said, et al.
International Journal of Cancer|October 14, 2014
Synergistic effect of JQ1 and rapamycin for treatment of human osteosarcomaDhong Hyun Lee, Jun Qi, James E Bradner, et al.
Leukemia Research|May 4, 2004
Allelic loss during progression of follicular lymphomaSeisho Takeuchi, Sven de Vos, Naoko Takeuchi, et al.
The Journal of Urology|November 17, 2007
In vivo efficacy of laparoscopic assisted percutaneous renal cryotherapy: evidence based guidelines for the practicing urologistAlberto Breda, John S Lam, Stephen Riggs, et al.
Pageof 13